SLC2A1 and gastric cancer: Glucose uptake in gastric cancer patients was measured in a previous study using F-fluorodeoxyglucose (FDG)-PET and except for signet-ring cell carcinoma, glucose uptake was enhanced in most gastric cancers exhibiting high levels of GLUT-1 (Alakus et al., 2010).